Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type I isolates into cell lines expressing CD4, CXCR4, and/or CCR5

Journal of Virology

Volumn 74, Issue 14, 2000, Pages 6377-6385

  Hug, Peter ^a   Lin, Han Ming Joseph ^a   Korte, Thomas ^a   Xiao, Xiaodong ^a   Dimitrov, Dimiter S ^a   Wang, Ji Ming ^a   Puri, Anu ^a   Blumenthal, Robert ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD4 ANTIGEN; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLOBOTRIAOSYLCERAMIDE; GLYCOPROTEIN GP 120; GLYCOSPHINGOLIPID; MONOSIALOGANGLIOSIDE;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CHEMOTAXIS; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; ANTIGENS, CD4; CELL MEMBRANE; ENZYME INHIBITORS; GLYCOSPHINGOLIPIDS; HELA CELLS; HIV-1; HUMANS; MEMBRANE FUSION; MICE; MORPHOLINES; PROTEIN CONFORMATION; RECEPTORS, CCR5; RECEPTORS, CXCR4; SPHINGOLIPIDS; TUMOR CELLS, CULTURED;

EID: 0033934279     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.14.6377-6385.2000     Document Type: Article

References (47)

1. Abe, A., J. Inokuchi, M. Jimbo, H. Shimeno, A. Nagamatsu, J. A. Shayman, G. S. Shukla, and N. S. Radin. 1992. Improved inhibitors of glucosylceramide synthase. J. Biochem. 111:191-196.
2. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
3. Ben-Baruch, A., L. Xu, P. R. Young, K. Bengali, J. J. Oppenheim, and J. M. Wang. 1995. Monocyte chemotactic protein-3 (MCP3) interacts, with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J. Biol. Chem. 270:22123-22128.
4. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
5. Berson, J. F., and R. W. Doms. 1998. Structure-function studies of the HIV-1 coreceptors. Semin, Immunol. 10:237-248.
6. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Canadian J. Biochem. Physiol. 37:911-917.
7. Broder, C. C., and E. A. Berger. 1995. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4* T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA 92:9004-9008.
8. Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111-136.
9. Cecilia, D., V. N. KewalRamani, J. O'Leary, B. Volsky, P. Nyambi, S. Burda, S. Xu, D. R. Littman, and S. Zolla-Pazner. 1998. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72:6988-6996.
10. Chabot, D. J., P. F. Zhang, G. V. Quinnan, and C. C. Broder. 1999. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J. Virol. 73:6598-6609.
11. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
12. Chieco-Bianchi, L., M. L. Calabro, M. Panozzo, A. De Rossi, A. Amadori, L. Callegaro, and A. Siccardi. 1989. CD4 modulation and inhibition of HIV-1 infectivity induced by monosialoganglioside GM1 in vitro. AIDS 3:501-507.
13. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
14. Dimitrov, D. S. 1997. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 91:721-730.
15. Dragic, T., L. Picard, and M. Alizon. 1995. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 69:1013-1018.
16. Earl, P. L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
17. Farzan, M., T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, N. P. Gerard, C. Gerard, J. Sodroski, and H. Choe. 1999. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96:667-676.
18. Freed, E. O., E. L. Delwart, G. L. Buchschacher, Jr., and A. T. Panganiban. 1992. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89:70-74.
19. Garofalo, T., M. Sorice, R. Misasi, B. Cinque, M. Giammatteo, G. M. Pontieri, M. G. Cifone, and A. Pavan. 1998. A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3. Involvement of serine phosphorylation and protein kinase c delta translocation. J. Biol. Chem. 273:35153-35160.
20. Hakomori, S. 1998. New insights in glycosphingolipid function: "glycosignaling domain." a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 8:xi-xix.
21. Hammache, D., N. Yahi, M. Maresca, G. Pieroni, and J. Fantini. 1999. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J. Virol. 73:5244-5248.
22. Ichikawa, S., and Y. Hirabayashi. 1998. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 8:198-202.
23. Jones, P. L., T. Korte, and R. Blumenthal. 1998. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273:404-409.
24. Kundu, S. K. 1981. Thin-layer chromatography of neutral glycosphingolipids and gangliosides. Methods Enzymol. 72:185-204.
25. Lapham, C. K., J. Ouyang, B. Chandrasekhar, N. Y. Nguyen, D. S. Dimitrov, and H. Golding. 1996. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274:602-605.
26. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
27. Millan, J., J. Cerny, V. Horejsi, and M. A. Alonso. 1999. CD4 segregates into specific detergent-resistant T-cell membrane microdomains. Tissue Antigens 53:33-40.
28. Moore, J. P., A. Trkola, and T. Dragic. 1997. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:551-562.
29. Munoz-Barroso, I., S. Durell, K. Sakaguchi, E. Appella, and R. Blumenthal. 1998. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140:315-323.
30. Nieva, J. L., R. Bron, J. Corver, and J. Wilschut. 1994. Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J. 13:2797-2804.
31. Offner, H., T. Thieme, and A. A. Vandenbark. 1987. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J. Immunol. 139: 3295-3305.
32. Oslermeyer, A. G., B. T. Beckrich, K. A. Ivarson, K. E. Grove, and D. A. Brown. 1999. Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells. Methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein. J. Biol. Chem. 274:34459-34466.
33. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Rabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage tropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
34. Puri, A., F. Booy, R. W. Doms, J. M. White, and R. Blumenthal. 1990. Conformational changes and fusion activity of influenza hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J. Virol. 64:3824-3832.
35. Puri, A., P. Hug, K. Jernigan, J. Barchi, H. Y. Kim, J. Hamilton, J. Wiels, G. J. Murray, R. O. Brady, and R. Blumenthal. 1998. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 95:14435-14440.
36. Puri, A., P. Hug, K. Jernigan, P. Rose, and R. Blumenthal. 1999. Role of glycosphingolipids in HIV-1 entry: requirement of globotriaosylceramide (Gb3) in CD4/CXCR4-dependent fusion. Biosci. Rep. 19:317-325.
37. Puri, A., P. Hug, I. Munoz-Barroso, and R. Blumenthal. 1998. Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells. Biochem. Biophys. Res. Commun. 242:219-225.
38. Puri, A., S. J. Morris, P. Jones, M. Ryan, and R. Blumenthal. 1996. Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins. Virology 219: 262-267.
39. Rogers, G. N., J. C. Paulson, R. S. Daniels, J. J. Skehel, I. A. Wilson, and D. C. Wiley. 1983. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304:76-78.
40. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569-572.
41. Smit, J. M., R. Bittman, and J. Wilschut. 1999. Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J. Virol. 73:8476-8484.
42. Sorice, M., I. Parolini, T. Sansolini, T. Garofalo, V. Dolo, M. Sargiacomo, T. Tai, C. Peschle, M. R. Torrisi, and A. Pavan. 1997. Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J. Lipid Res. 38:969-980.
43. Suzuki, Y., T. Suzuki, M. Matsunaga, and M. Matsumoto. 1985. Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus. J. Biochem. 97:1189-1199.
44. Ugolini, S., I. Mondor, and Q. J. Sattentau. 1999. HIV-1 attachment: another look. Trends Microhiol. 7:144-149.
45. Weissenhorn, W., A. Dessen, L. J. Calder, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1999. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16:3-9.
46. Wyalt, R., and J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
47. Xiao, X., L. Wu, T. S. Stantchev, Y. R. Feng, S. Ugolini, H. Chen, Z. Shen, J. L. Riley, C. C. Broder, Q. J. Sattentau, and D. S. Dimitrov. 1999. Constitutive cell surface association between CD4 and CCR5. Proc. Natl. Acad. Sci. USA 96:7496-7501.